EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY-NC-ND 4.0

Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development

Vaidehi Nafade, Naheemot O Sule, Yang Zhang, Angelina Sassi, Nicole E Basta iD

Tropical Medicine & International Health · 2026

DOI: 10.1111/tmi.70070 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Tropical Medicine & International Health, 2026. Verfasst von Vaidehi Nafade und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, M…. Hauptthemen laut MEDLINE: Diarrhea, Enterotoxigenic Escherichia coli, Escherichia coli Infections, Escherichia coli Vaccines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tier 2 Canada Research Chair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The primary objectives of this study are to (1) summarise the current landscape of ETEC vaccine development by describing, characterising and comparing ETEC vaccine candidates in clinical development, (2) assess key characteristics of the phases 1, 2 and 3 clinical trials that have been designed to evaluate ETEC vaccines in development and (3) compare ETEC vaccine candidates being evaluated in clinical trials to the WHO Preferred Product Characteristics (PPC) for an ETEC vaccine.

Methods

To identify vaccine candidates, we searched 24 trial registries and PubMed. Searches were completed on 6 February 2024 and updated on 27 September 2024. We extracted information about the characteristics of each vaccine candidate and information about the most recently registered clinical trial for candidates in active development. We qualitatively synthesised the information available and compared each vaccine candidate to the WHO PPC.

Results

Our search returned 262 trial records and 821 publications, from which we identified 13 unique vaccine candidates with clinical development spanning three decades, with six vaccine candidates that had at least one clinical trial registered in 2014 or later. These six candidates (dmLT, dscCfAE, ETVAX, CssBA, CVD1208S‐122 and ShigETEC) are in Phase 1 or Phase 2 trials with sample sizes from 50 to 4936 participants, with no Phase 3 trials registered by September 2024. Trials take place in the United States, Bangladesh and the Gambia. The candidates vary in their route of administration (oral, intradermal, intramuscular). Two candidates are being evaluated as two doses with or without a booster, and four require three doses. Three candidates are adjuvanted. Most trials are evaluating endpoints about safety and reactogenicity.

Conclusions

We identified diverse ETEC vaccine candidates. Comparison with the PPC emphasised differences in approach and the limited information available from early‐stage trials, and the importance of generating evidence for populations with a high burden of ETEC diarrhoea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiarrheaEnterotoxigenic Escherichia coliEscherichia coli InfectionsEscherichia coli VaccinesVaccine DevelopmentHumansClinical Trials as Topic

Stichwörter der Autor:innen

ETECbacterial pathogensclinical trialtraveller's diarrhoeavaccine candidatevaccine development

Substanzen

Escherichia coli Vaccines

Autor:innen und Institutionen

  • Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Nicole E Basta

Förderung

  • Tier 2 Canada Research Chair

Zitieren

APA

Nafade, V., Sule, N. O., Zhang, Y., Sassi, A., & Basta, N. E. (2026). Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.70070

Vancouver

Nafade V, Sule NO, Zhang Y, Sassi A, Basta NE. Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development. Tropical Medicine & International Health. 2026. doi:10.1111/tmi.70070

BibTeX
@article{Nafade2026,
  author = {Nafade, Vaidehi and Sule, Naheemot O and Zhang, Yang and Sassi, Angelina and Basta, Nicole E},
  title = {Vaccine Candidates Designed to Prevent Enterotoxigenic Escherichia coli Diarrhoea: A Scoping Review of Clinical Trials Evaluating Vaccine Candidates in Development},
  journal = {Tropical Medicine & International Health},
  year = {2026},
  doi = {10.1111/tmi.70070}
}
Kostenlos starten →